SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BMcV who wrote (3054)5/27/1999 9:31:00 AM
From: chirodoc   of 10280
 
drugs are out of favor, sepr is out of favor.......
any time you can buy a drug company with this many drugs in the pipeline, with such an efficient FDA preparation process 50% below its high (albeit the high was a bit inflated),there is market capitulation.

i am still buying this company and look forward to a stock price in 1-2 years that will make me smile.

as a chiropractor i treat thousands of patients every year. i guarantee you they will choose a drug with less side effects over one with more, they will choose oral before injection--anyday.

even without a great sales force, this company will continue to add to the market, every year, a drug or two that will have less side effects than a competitor. forget all of the new drugs coming to market as a huge threat. most patients still take motrin and will continue to take drugs that they feel are safe, easy-to-take and effective. this will be a powerful drug company in 5 years.

i am also buying more pfizer--what a gift.

curtis
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext